The statistical risk of diagnosing coincidental acquired hemophilia A following anti‐SARS‐CoV‐2 vaccination

We read with interest the case report by Radwi et al. of a 69 year-old man with acquired hemophilia A (AHA) following vaccination with the Pfizer-BioNTech SARS CoV-2 mRNA vaccine (1). The publication prompted us to perform a survey within the Working Party Haemostasis of the Swiss Society of Hematol...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Thrombosis and Haemostasis 2021-09, Vol.19 (9), p.2360-2362
Main Authors: Cittone, Micol G., Battegay, Raphael, Condoluci, Adalgisa, Terzi di Bergamo, Lodovico, Fernandes, Eliana, Galfetti, Elena, Noseda, Roberta, Leuppi‐Taegtmeyer, Anne, Drexler, Beatrice, Ceschi, Alessandro, Tsakiris, Dimitrios A., Berger, Christoph T., Favre, Genevieve, Martin, Thomas, Korte, Wolfgang, Graf, Lukas, Martinez, Maria, Gerber, Bernhard
Format: Article
Language:English
Subjects:
acquired hemophilia A
AHA
COVID-19
Hemophilia
Hemophilia A - diagnosis
hemostasis
Humans
Letter to the Editor
SARS-CoV-2
SARS‐CoV‐2 vaccine
Severe acute respiratory syndrome coronavirus 2
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We read with interest the case report by Radwi et al. of a 69 year-old man with acquired hemophilia A (AHA) following vaccination with the Pfizer-BioNTech SARS CoV-2 mRNA vaccine (1). The publication prompted us to perform a survey within the Working Party Haemostasis of the Swiss Society of Hematology to detect similar cases in Switzerland. The survey led to the identification of three cases of AHA in Switzerland between December 23rd 2020 and April 30th 2021.
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1111/jth.15421